Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.
More info
engnldfra
Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million

Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million

Menarini Group  and Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, (Nasdaq: STML) today announced a definitive agreement under which Menarini Group will acquire Stemline in a transaction valued up to $677 million.
Read More

News

May 04 2020
Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
Menarini Group  and Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel...
Apr 02 2020
COVID-19 Menarini Diagnostics: kit for diagnosis in 20 minutes
A. Menarini Diagnostics and Credo Diagnostics Biomedical have entered into an exclusive distribution agreement for the  SARS-CoV-2 assay kit  and o...
Mar 16 2020
Covid-19: Menarini Group converts production plant to produce and donate disinfectant gel
Menarini will be producing 5 tons of disinfectant gel per week which will be distributed throughout the Italian territory and  free of charge by   ...

OUR VALUES

10 core values which originated our group's success. READ MORE »

DIVISION DIAGNOSTICS

Advanced technology. READ MORE »

QUALITY FIRST

Quality: starting point and endpoint criteria for our medicines. READ MORE »

MENARINI IN THE WORLD

The Menarini Group has companies located almost all over the world. READ MORE »
Scroll Top